| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,285 |
6,795 |
$297K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
671 |
590 |
$40K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
980 |
838 |
$33K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,357 |
1,913 |
$21K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
247 |
189 |
$17K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
491 |
463 |
$16K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,711 |
1,392 |
$15K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,593 |
1,244 |
$14K |
| 92551 |
|
1,469 |
1,156 |
$11K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,528 |
2,276 |
$9K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
213 |
157 |
$7K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
583 |
472 |
$7K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
51 |
50 |
$5K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
203 |
195 |
$4K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
52 |
40 |
$4K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
49 |
47 |
$4K |
| 99173 |
|
1,476 |
1,157 |
$3K |
| 99401 |
|
309 |
186 |
$3K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
30 |
26 |
$3K |
| 93000 |
|
405 |
359 |
$3K |
| 80061 |
Lipid panel |
300 |
275 |
$2K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
95 |
83 |
$2K |
| 96160 |
|
747 |
613 |
$1K |
| 85018 |
|
1,164 |
1,055 |
$1K |
| 99384 |
|
15 |
12 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,148 |
878 |
$1K |
| 96127 |
|
438 |
356 |
$961.70 |
| 99442 |
|
33 |
28 |
$887.74 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
29 |
28 |
$785.28 |
| 99490 |
Ccm add 20min |
99 |
95 |
$712.44 |
| 82947 |
|
309 |
268 |
$641.65 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
566 |
453 |
$302.39 |
| 90686 |
|
101 |
73 |
$224.65 |
| 99491 |
Ccm add 20min |
27 |
15 |
$192.49 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
257 |
200 |
$86.83 |
| 90756 |
|
17 |
16 |
$66.84 |
| 1159F |
|
150 |
131 |
$6.48 |
| 36416 |
|
567 |
517 |
$5.75 |
| 3288F |
|
108 |
91 |
$4.69 |
| 3725F |
|
223 |
188 |
$2.92 |
| 90649 |
|
101 |
98 |
$0.16 |
| 99497 |
|
182 |
158 |
$0.00 |
| 1090F |
|
58 |
53 |
$0.00 |
| 1160F |
|
59 |
52 |
$0.00 |
| 90715 |
|
12 |
12 |
$0.00 |
| 1170F |
|
256 |
228 |
$0.00 |
| 99606 |
|
88 |
79 |
$0.00 |
| 90733 |
|
18 |
12 |
$0.00 |
| 1126F |
|
60 |
52 |
$0.00 |